CLINICAL SUPPLY CHAINS
End-to-End Control
from Development to Delivery
Highly orchestrated, technology-enabled clinical supply chains designed around patient timelines, supporting IMP, CTS, Named Patient, Expanded Access
Clinical supply chains demand more than logistics.
A true 360° supply chain—connecting therapies, depots, clinical sites, and ultimately, the patient.
An Intelligent Supply Chain for your Life-Saving Therapies.
From Manufacturing Origin
Coordinating at scale from the point of manufacture to the first point of distribution.
To Central, Regional, or In-Country Depots
Intelligent modeling to ensure strategically positioned inventory to provide supply continuity across all trial geographies.
To Clinical Trial Sites and Hospitals
Whether you opt for in-country distribution or import your IMP, EF Healthcare provides last-mile delivery to sites and patients, on time and within specification.
EXPANDED ACCESS PROGRAMS / COMPASSIONATE USE
Because there is a Patient Waiting
-
Scalable yet controlled distribution models
-
Regulatory and documentation support
-
Temperature and chain of custody integrity
-
Close coordination with sponsors, physicians, and sites
NAMED PATIENT PROGRAMS
Urgent access. Zero compromise.
-
Rapid-response logistics and regulatory coordination
-
Country-specific import/export expertise
-
Patient-specific shipment orchestration
-
White-glove, time-critical delivery
Common Questions
Frequently asked questions
01 What types of clinical supply chains do you support?
EF Healthcare has deep expertise in designing resilient and scalable supply chains for Phase I-IV clinical trials across all therapeutic areas (oncology, cardiovascular, endocrinology, etc), 200+ geographies, and covering all therapeutic modalities (small/large molecule, vaccines, CGT, RNAi, etc).
02 How do you manage the complexity and scale of a global Phase III trial?
03 Do you have experience supporting Named Patient, Expanded Access, and Compassionate Use supply chains?
04 How do you ensure temperature integrity for clinical shipments?
05 How do you support study scale up from a smaller Phase I trial to a larger Phase IIB or Phase III trial?
EF Healthcare leverages its ClearLink IT platform as one source of truth to deliver real-time visibility, standardized workflows, and a scalable data architecture that seamlessly expands from a Phase I to global Phase III trial. Our systems enable the rapid onboarding of new sites, depots, and lane, while we simultaneously maintain consistent quality standards and processes at scale, with our team’s expertise ensuring fast, reliable execution without compromising compliance or control.
